Table 1 Characteristics of the study population treated with and without statin
| Â | Whole blood | Â | Plasma | Â | ||
|---|---|---|---|---|---|---|
|  | Control(n = 10) | Stain(n = 10) | p value | Control(n = 5) | Stain(n = 5) | p value |
General data | Â | Â | Â | Â | Â | Â |
  Sex, M/F | (4/6) | (5/5) | >0.99 | (3/2) | (1/4) | 0.524 |
  Age(yrs) | 59 ± 7.9 | 56 ± 7.6 | 0.394 | 59 ± 4.2 | 64 ± 9.9 | 0.343 |
  SBP(mm Hg) | 135 ± 15.1 | 131 ± 15.6 | 0.889 | 131 ± 12.1 | 128 ± 16.4 | 0.758 |
  DBP(mm Hg) | 80 ± 7.1 | 82 ± 12.4 | 0.591 | 78 ± 8.1 | 75 ± 11.2 | 0.669 |
Medical history | Â | Â | Â | Â | Â | Â |
  Hypertension(%) | 90(9/10) | 80(8/10) | >0.99 | 60(3/5) | 100(5/5) | 0.444 |
  Diabetes(%) | 0(0/10) | 0(0/10) | >0.99 | 20(1/5) | 20(1/5) | >0.99 |
  Hyperlipaemia(%) | 30(3/10) | 50(5/10) | 0.649 | 60(3/5) | 100(5/5) | 0.444 |
  Cerebral vascular disease (%) | 0(0/10) | 0(0/10) | >0.99 | 0(0/5) | 0(0/5) | >0.99 |
  Smoking(%) | 20(2/10) | 0(0/10) | 0.474 | 40(2/5) | 0(0/5) | 0.444 |
Laboratory test | Â | Â | Â | Â | Â | Â |
  Glucose(mmol/l) | 5.4 ± 1.2 | 5.2 ± 1.4 | 0.796 | 4.8 ± 0.6 | 5.1 ± 0.6 | 0.526 |
  LDL cholesterol (mmol/l) | 2.5 ± 0.9 | 2.2 ± 0.9 | 0.577 | 2.6 ± 0.7 | 2.4 ± 0.4 | 0.605 |
  HDl cholesterol (mmol/l) | 1.0 ± 0.1 | 1.1 ± 0.3 | 0.314 | 1.2 ± 0.3 | 0.8 ± 0.1 | 0.034* |
  TC (mmol/l) | 4.3 ± 0.9 | 4.0 ± 1.1 | 0.364 | 4.3 ± 0.5 | 3.9 ± 0.6 | 0.462 |
  TG(mmol/l) | 1.3 ± 0.6 | 1.2 ± 0.7 | 0.496 | 1.6 ± 0.2 | 1.6 ± 0.3 | 0.897 |
  Creatinine(mg/dl) | 60.7 ± 13.5 | 62.5 ± 18.8 | 0.781 | 76.2 ± 13.5 | 62.0 ± 20.2 | 0.781 |
  alt(u/l) | 28.9 ± 16.8 | 20.7 ± 9.2 | 0.211 | 21.6 ± 17.2 | 17.6 ± 5.3 | 0.616 |
  ast(u/l) | 23.4 ± 11.2 | 18.1 ± 4.27 | 0.224 | 18.8 ± 8.3 | 18.4 ± 2.3 | 0.897 |
Medication | Â | Â | Â | Â | Â | Â |
  Aspirin(%) | 30(3/10) | 50(5/10) | 0.649 | 40(2/5) | 60(3/5) | >0.99 |
  Clopidogrel(%) | 30(3/10) | 30(3/10) | >0.99 | 20(1/5) | 60(3/5) | 0.524 |
  Calcium antagonists (%) | 40(4/10) | 20(2/10) | 0.628 | 40(2/5) | 20(1/5) | >0.99 |
  ACEI/ARBs(%) | 50(5/10) | 20(2/10) | 0.349 | 0(0/5) | 20(1/5) | >0.99 |
  β-Blockers(%) | 20(2/10) | 40(4/10) | 0.628 | 40(2/5) | 40(2/5) | >0.99 |